Proxinse
Latest round
- Series A
Last raised
- Oct 2022
Total raised
- Undisclosed
Investors
- 3
About Proxinse
Based in Shenzhen, China and established in 2017, Proxinse is a medical equipment company that provides minimally invasive surgical endoscope. The founder Huihai Lu is a doctor of Electronics from University of Essex in the UK. The co-founder Decai Wang has 20 years experience in hardware design and software development of electronic products. The company has three core products: 4K ultra high definition laparoscopic system, 3D electronic laparoscopic system, and fluorescent endoscopic system. The products help doctors get more detail on the images during the surgery.
Who invested in Proxinse
3 investors across 1 round
See all investors in Proxinse
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 13, 2022
Amount
Undisclosed
Investors
Questions about Proxinse
Who invested in Proxinse?
Proxinse has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Proxinse raised?
Proxinse has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Proxinse last raise money?
Proxinse's most recent round on record is a Series A, in Oct 2022.
What does Proxinse do?
Based in Shenzhen, China and established in 2017, Proxinse is a medical equipment company that provides minimally invasive surgical endoscope.
Where is Proxinse headquartered?
Proxinse is headquartered in Shenzhen, China.
Which VCs invest in companies like Proxinse?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Proxinse's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Proxinse? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.